OptimizeRx Expands Programmatic Reach With The Trade Desk Deal

By Elena Vasquez

More than 99% of OptimizeRx's advertising business has been tied to prescription drug brands — and its new partnership with The Trade Desk, struck this month, is designed to change that. The deal extends the company's programmatic ambitions beyond an earlier arrangement with the healthcare-focused DSP DeepIntent, SVP of strategic market intelligence Maria Cipicchio told AdExchanger.

OptimizeRx sells software subscriptions to healthcare providers. Its ad inventory sits entirely inside HCP (healthcare provider) electronic health records, visible only within the doctor's log-in portal at the point of care.

How the targeting works

Every impression targets a National Provider Identifier (NPI), the unique medical identifier assigned to each prescribing doctor. The identifier persists across a doctor's entire career, unlike cookie-based web or CTV targeting.

Buyers therefore know exactly who sees each ad. There are no bots, Cipicchio said. Every ad loads fully in view and never sits below the fold.

Before programmatic, OptimizeRx earned marketing revenue through a different mechanism. Pharmaceutical brands offered financial incentives — essentially covering part of drug costs — to influence prescribing choices, Cipicchio said.

Why did programmatic take longer?

The company moved deliberately. "We knew that we needed to enter the [programmatic] space very carefully," Cipicchio told AdExchanger.

Programmatic units raised two sets of concerns. First, pharma marketers do not want ads placed alongside actual patient data — not a government rule, but an industry priority. Second, OptimizeRx vets every ad creative to ensure nothing feels errant or misleading to the doctor, and that each ad focuses on relevant healthcare data about its product.

"But the buyer doesn't ever see that aspect of it, which is one of the beauties of programmatic," she said.

What does The Trade Desk add?

DeepIntent operates inside the same regulatory bubble as OptimizeRx, since both are healthcare-focused. The Trade Desk integration opens a general-purpose demand path.

Part of the appeal is OpenPath, The Trade Desk's direct supply connection, which would let the DSP analyze ads served within the HCP EHR against campaigns on streaming TV or other channels.

The bigger prize is advertiser diversification. Doctors frequently recommend over-the-counter products such as Nyquil or Tylenol during ongoing patient care, Cipicchio noted.

"Every skincare product wants a doctor to recommend their product," she said. An over-the-counter allergy brand, for example, could use The Trade Desk's system to target geographic areas during allergy breakout seasons such as spring pollen.

Those remain sales pitches for now. But "there's no restriction on that in the programmatic arena," Cipicchio said — which positions a prescription-dominated point-of-care inventory to court consumer brands for the first time.